Aggregation Properties of a Polymeric Anticancer Therapeutic: A Coarse-Grained Modeling Study
暂无分享,去创建一个
Lei Yu | Lili X. Peng | Stephen B. Howell | David A. Gough | S. Howell | Lei Yu | D. Gough
[1] R. Larson,et al. The MARTINI Coarse-Grained Force Field: Extension to Proteins. , 2008, Journal of chemical theory and computation.
[2] Bernhardt L. Trout,et al. Design of therapeutic proteins with enhanced stability , 2009, Proceedings of the National Academy of Sciences.
[3] S. Nie,et al. Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .
[4] Amedeo Caflisch,et al. Computational models for the prediction of polypeptide aggregation propensity. , 2006, Current opinion in chemical biology.
[5] John M. Veranth,et al. ZnO particulate matter requires cell contact for toxicity in human colon cancer cells. , 2010, Chemical research in toxicology.
[6] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[7] Wilfred F. van Gunsteren. Molecular dynamics studies of proteins , 1993 .
[8] M J Cass,et al. Brownian dynamics simulations of associating diblock copolymers. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[9] Ruth Nussinov,et al. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. , 2006, Current opinion in chemical biology.
[10] D. Tieleman,et al. The MARTINI force field: coarse grained model for biomolecular simulations. , 2007, The journal of physical chemistry. B.
[11] Andreas Vitalis,et al. Thermodynamics of beta-sheet formation in polyglutamine. , 2009, Biophysical journal.
[12] Scott E McNeil,et al. Nanomaterial standards for efficacy and toxicity assessment. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[13] Amedeo Caflisch,et al. Interpreting the aggregation kinetics of amyloid peptides. , 2006, Journal of molecular biology.
[14] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[15] Ned S. Wingreen,et al. Chemotaxis in Escherichia coli: A Molecular Model for Robust Precise Adaptation , 2007, PLoS Comput. Biol..
[16] Kevin Robbie,et al. Nanomaterials and nanoparticles: Sources and toxicity , 2007, Biointerphases.
[17] Joan-Emma Shea,et al. Self-assembly of β-sheet forming peptides into chiral fibrillar aggregates , 2007 .
[18] Gunnar Rätsch,et al. Support Vector Machines and Kernels for Computational Biology , 2008, PLoS Comput. Biol..
[19] Salvador Ventura,et al. Prediction of "hot spots" of aggregation in disease-linked polypeptides , 2005, BMC Structural Biology.
[20] W. Nowicki,et al. Model of aggregation of colloidal fine particles in the presence of supersized polymer , 1995 .
[21] A. Mark,et al. Coarse grained model for semiquantitative lipid simulations , 2004 .
[22] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[23] Pratim Biswas,et al. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies , 2009 .
[24] John D Sherwood,et al. A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization. , 2002, Journal of pharmaceutical sciences.
[25] Vicki Stone,et al. Toxicology of nanoparticles: A historical perspective , 2007 .
[26] Dusan Bratko,et al. Molecular simulation of protein aggregation , 2007, Biotechnology and bioengineering.
[27] Sabine Neuss,et al. Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.